 | Up a level |
Tarantino, Ignazio; Warschkow, Rene; Worni, Mathias; Cerny, Thomas; Ulrich, Alexis; Schmied, Bruno M; Güller, Ulrich (2015). Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. Annals of surgery, 262(1), pp. 112-120. Lippincott Williams & Wilkins 10.1097/SLA.0000000000000860
Castleberry, A. W.; Güller, Ulrich; Tarantino, I.; Berry, M. F.; Brügger, Lukas; Warschkow, R.; Cerny, Thomas; Mantyh, C. R.; Candinas, Daniel; Worni, Mathias (2014). Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis. Journal of gastrointestinal surgery, 18(6), pp. 1194-1204. Springer 10.1007/s11605-014-2515-3
Cerny, David; Cerny, Thomas; Ess, Silvia; D'Addario, Giannicola; Früh, Martin (2009). Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival. Onkologie, 32(10), pp. 569-573. Karger 10.1159/000232581
Von Rohr, A.; Schmitz, S.-F. H.; Tichelli, A.; Hess, U.; Piguet, D.; Wernli, M.; Frickhofen, N.; Konwalinka, G.; Zulian, G.; Ghielmini, M.; Rufener, B.; Racine, C.; Fey, M. F.; Cerny, T.; Betticher, D.; Tobler, A. (2002). Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology, 13(10), pp. 1641-1649. Oxford University Press 10.1093/annonc/mdf272
Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598
Stupp, R.; Bauer, J.; Pagani, O.; Gerard, B.; Cerny, T.; Sessa, C.; Bastian, G.; Sarkany, M.; Schläpfer, J.; Giroux, B.; Leyvraz, S. (1998). Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of oncology, 9(11), pp. 1233-1242. Oxford University Press 10.1023/A:1008495919071
Als, C.; Laeng, H.; Cerny, T.; Kinser, J. A.; Rösler, H.; Häusler, R. (1998). Primary cervical malignant teratoma with a rib metastasis in an adult: Five-year survival after surgery and chemotherapy. Annals of oncology, 9(9), pp. 1015-1022. Oxford University Press 10.1023/A:1008277227111
Buser, K.; Joncourt, F.; Altermatt, H.J.; Bacchi, M.; Oberli, A.; Cerny, Th. (1997). Breast cancer: Pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Annals of oncology, 8(4), pp. 335-341. Kluwer Academic Publishers 10.1023/A:1008202723066
Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A. (1997). Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation. Annals of oncology, 8(6), pp. 604-606. Oxford University Press 10.1023/A:1008245709924
Pagani, O.; Sessa, C.; Martinelli, G.; Cerny, Thomas; De Jong, J.; Goldhirsch, A.; Zimatore, M.; Cavalli, F. (1997). Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer. Annals of oncology, 8(7), pp. 655-661. Oxford University Press 10.1023/A:1008211629858
Betticher, D. C.; Zucca, E.; Von Rohr, A.; Egger, T.; Radford, J. A.; Ambrosetti, A.; Bürki, K.; Rufener, B.; Hsu Schmitz, S. F.; Cerny, Thomas (1996). 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma. Annals of oncology, 7(8), pp. 793-799. Oxford University Press 10.1093/oxfordjournals.annonc.a010757
